Hot off the press…

News

Follow us in every step, as we continue to enable life scientists to accelerate discovery by providing cutting-edge tools for molecular interaction analysis

All news

Domainex invests in the Creoptix WAVEdelta to strengthen its fragment-based drug discovery platform

Jan 12, 2021

Strong partnership ahead
Creoptix and oneservice Partner for WAVEsystem After-Sales Support

Nov 25, 2020

Together we meet the needs of our customers
The Throughput Booster for your Binding Interaction Screen

Nov 20, 2020

Online Event
Creoptix and 2bind Sign Technology-Service Partnership

Nov 17, 2020

Together we will continue offering customers the highest quality research tools and help them accelerate their R&D
The Virtual Seminar Series on Biomolecular Interaction Analysis

Nov 5, 2020

Let's Talk Kinetics! with Kelvin Lau - EPFL
Creoptix on a Quest to Change Drug Discovery

Nov 4, 2020

at SwissCanto Invest, Investor Event 2020
Creoptix "Under the Microscope" with leadXpro

Sep 16, 2020

Transforming drug discovery on membrane proteins - together
Creoptix @PEGS Boston 2020 - Virtual Edition

Aug 8, 2020

Discover the benefits of early stage kinetic characterization from crude samples with our Application Scientist Rony Nehmé
Creoptix Announces New Board Members

Jul 16, 2020

Welcome Dr. Chris Radloff and Nicola Bramwell
Line Stigen Raquet Interviewed by Startup Valley Magazine

Jun 17, 2020

Read Line's top 3 tips for future female founders
Creoptix Supporting COVID-19 Research with its Bioanalytical Instruments and Partnerships in Switzerland

May 27, 2020

Accelerating COVID-19 Research
Creoptix Supporting COVID-19 Research

May 15, 2020

Committed to enabling hospitals and clinical researchers with high performance solutions to characterize binding affinity and kinetics of antibodies on SARS-CoV-2
Creoptix Listed Under Swiss Startups Tackling Coronavirus

May 13, 2020

Accelerating COVID-19 research
Creoptix Collaborates with Prof. Adriano Aguzzi and the University of Zurich

May 13, 2020

Collaboration aimed at characterizing anti-SARS-CoV-2 antibodies in patients with coronavirus
The WAVE lands in San Carlos at MBC BioLabs

Feb 20, 2020

Enabling scientist deliver awesome science
Creoptix Appoints Line Stigen Raquet as Chief Executive Officer

Dec 10, 2019

Welcome Line Stigen Raquet!
The WAVE Community Keeps Growing

Dec 2, 2019

Another WAVE installed, this time in Italy!
Creoptix Closes Successful Series C Financing Round

Sep 30, 2019

Supporting further growth
Genedata Ready-to-Run Creoptix

Jun 3, 2019

The WAVEsystems are now Genedata compatible
Creoptix Strengthens Senior Management Team

Mar 1, 2019

Welcome Gareth Jones
Biomolecular Interactions Workshop in Boston, Massachusetts

Oct 30, 2018

Introduction to GCI label-free kinetics at MassBio
Creoptix Welcomes Kevin M. Jackvony as National Sales Manager - US & Canada

Oct 11, 2018

Strengthening sales efforts in the US
Catch the WAVE of the Future in Kinetics!

Oct 5, 2018

This is your chance to tell us about your wishes in label-free sensing and kinetics
Creoptix Participates in the Festival of Biologics - 2018

Oct 5, 2018

Get your free pass now and meet us in Basel!
Creoptix Attracts Waters as Corporate Investor

Sep 6, 2018

"Proud to be partnering with Waters Corporation"
Creoptix Sponsors Talk at Discovery on Target 2018

Sep 5, 2018

Don't miss Michael Hennig's talk!
Creoptix Sponsors Session at VI Workshop on Plants, Peptides & Receptors 2018

Sep 5, 2018

See you in Málaga!
Universal Drug-Binding Mechanism to Aurora A Kinase Studied Using the Creoptix WAVEsystem

Aug 27, 2018

Congratulations Dorothee Kern and team!
The Creoptix WAVEsystem Helps Reveal New Insights in Brassinosteroid Signaling

May 1, 2018

Michael Hothorn's lab latest work in Nature Plants
Creoptix Enters UK Market with Mologic

Nov 9, 2017

The WAVE lands in Bedford Technology Park, United Kingdom
Creoptix is Hiring Sales Representatives

Jun 29, 2017

Check out our careers page
Creoptix is Hiring a Field Application Scientist – US Territory

Oct 28, 2016

Check out our careers page
Creoptix is Hiring

May 19, 2016

Check out our careers page
Small Molecules Can't Hide Anymore...

May 3, 2016

not even behind large drug targets!
New TechNotes

Sep 22, 2015

Discover the benefits of the Creoptix^® WAVE system for molecular interaction analysis
Merck Technology Symposium - 2015

May 21, 2015

Looking forward to meeting you!
Creoptix at Drug Discovery Chemistry 2015

Apr 20, 2015

Looking forward to meeting you!
Creoptix at Fragments 2015

Mar 22, 2015

Looking forward to meeting you!
Creoptix at Label-Free Technologies Conference 2015

Mar 12, 2015

Looking forward to meeting you!
Workshop on March 11 at Swissnex Boston

Feb 24, 2015

With Dr. Walter Huber
Late Night with LRIG

Jan 15, 2015

We look forward to seeing you soon in Washington!
Creoptix at Swiss Innovation Forum 2014

Nov 17, 2014

Meet us in Basel!
Creoptix at 10th Annual European Antibody Congress 2014

Nov 4, 2014

Meet us in Geneva!
Creoptix at Fragment-based Lead Discovery Conference 2014

Sep 11, 2014

Meet us in Basel!
New Carbonic Anhydrase Data - WAVEsystem

Sep 3, 2014

Outstanding sensitivity
Launch of the WAVE system

Aug 30, 2014

A system for high-sensitive label-free analysis of molecular interactions
New Facilities for Creoptix

Jul 1, 2014

We've moved!
Creoptix to Support the 15th Annual Drug Discovery Summit 2014

May 7, 2014

See you in Geneva!

Creoptix^®, WAVEchip^®, WAVEcore^® and waveRAPID^® are registered trademarks of Creoptix AG.

Hot off the press…

News

Categories

All news

Domainex invests in the Creoptix WAVEdelta to strengthen its fragment-based drug discovery platform

Creoptix and oneservice Partner for WAVEsystem After-Sales Support

The Throughput Booster for your Binding Interaction Screen

Creoptix and 2bind Sign Technology-Service Partnership

The Virtual Seminar Series on Biomolecular Interaction Analysis

Creoptix on a Quest to Change Drug Discovery

Creoptix "Under the Microscope" with leadXpro

Creoptix @PEGS Boston 2020 - Virtual Edition

Creoptix Announces New Board Members

Line Stigen Raquet Interviewed by Startup Valley Magazine

Creoptix Supporting COVID-19 Research with its Bioanalytical Instruments and Partnerships in Switzerland

Creoptix Supporting COVID-19 Research

Creoptix Listed Under Swiss Startups Tackling Coronavirus

Creoptix Collaborates with Prof. Adriano Aguzzi and the University of Zurich

The WAVE lands in San Carlos at MBC BioLabs

Creoptix Appoints Line Stigen Raquet as Chief Executive Officer

The WAVE Community Keeps Growing

Creoptix Closes Successful Series C Financing Round

Genedata Ready-to-Run Creoptix

Creoptix Strengthens Senior Management Team

Biomolecular Interactions Workshop in Boston, Massachusetts

Creoptix Welcomes Kevin M. Jackvony as National Sales Manager - US & Canada

Catch the WAVE of the Future in Kinetics!

Creoptix Participates in the Festival of Biologics - 2018

Creoptix Attracts Waters as Corporate Investor

Creoptix Sponsors Talk at Discovery on Target 2018

Creoptix Sponsors Session at VI Workshop on Plants, Peptides & Receptors 2018

Universal Drug-Binding Mechanism to Aurora A Kinase Studied Using the Creoptix WAVEsystem

The Creoptix WAVEsystem Helps Reveal New Insights in Brassinosteroid Signaling

Creoptix Enters UK Market with Mologic

Creoptix is Hiring Sales Representatives

Creoptix is Hiring a Field Application Scientist – US Territory

Creoptix is Hiring

Small Molecules Can't Hide Anymore...

New TechNotes

Merck Technology Symposium - 2015

Creoptix at Drug Discovery Chemistry 2015

Creoptix at Fragments 2015

Creoptix at Label-Free Technologies Conference 2015

Workshop on March 11 at Swissnex Boston

Late Night with LRIG

Creoptix at Swiss Innovation Forum 2014

Creoptix at 10th Annual European Antibody Congress 2014

Creoptix at Fragment-based Lead Discovery Conference 2014

New Carbonic Anhydrase Data - WAVEsystem

Launch of the WAVE system

New Facilities for Creoptix

Creoptix to Support the 15th Annual Drug Discovery Summit 2014